KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Treasury Shares (2016 - 2025)

Bausch Health Companies' Treasury Shares history spans 14 years, with the latest figure at $3.8 million for Q4 2025.

  • On a quarterly basis, Treasury Shares fell 7.32% to $3.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.8 million, a 7.32% decrease, with the full-year FY2025 number at $3.8 million, down 7.32% from a year prior.
  • Treasury Shares hit $3.8 million in Q4 2025 for Bausch Health Companies, down from $4.1 million in the prior quarter.
  • Over the last five years, Treasury Shares for BHC hit a ceiling of $8.3 million in Q4 2022 and a floor of $3.8 million in Q4 2025.
  • Historically, Treasury Shares has averaged $5.4 million across 5 years, with a median of $5.3 million in 2023.
  • Biggest five-year swings in Treasury Shares: surged 53.7% in 2022 and later tumbled 36.14% in 2023.
  • Tracing BHC's Treasury Shares over 5 years: stood at $5.4 million in 2021, then surged by 53.7% to $8.3 million in 2022, then tumbled by 36.14% to $5.3 million in 2023, then fell by 22.64% to $4.1 million in 2024, then dropped by 7.32% to $3.8 million in 2025.
  • Business Quant data shows Treasury Shares for BHC at $3.8 million in Q4 2025, $4.1 million in Q4 2024, and $5.3 million in Q4 2023.